Showing results (131-140 of 190) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|July 19, 2011
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)Lara E Sucheston, Hua Zhao, Song Yao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancerGeorge T Budd, William E Barlow, Halle C F Moore, et al.The New England Journal of Medicine|March 5, 2015
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyHalle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.Journal of the National Cancer Institute|October 30, 2018
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230Halle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 19, 2019
NCCN Guidelines Insights: Survivorship, Version 2.2019Tara Sanft, Crystal S Denlinger, Saro Armenian, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
NCCN Guidelines Insights: Survivorship, Version 2.2020Crystal S Denlinger, Tara Sanft, Javid J Moslehi, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2024
NCCN Guidelines® Insights: Survivorship, Version 2.2024Tara Sanft, Andrew T Day, Mindy Goldman, et al.European Journal of Cancer (Oxford, England : 1990)|April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort studyIsotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.The New England Journal of Medicine|June 6, 2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, William Jacot, Toshinari Yamashita, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE TrialFedro A Peccatori, Samuel M Niman, Ann H Partridge, et al.Pageof 19